HF
IMA

HRT Financial’s ImageneBio Inc IMA Stock Holding History

HRT Financial’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
+13,909
New +$90.3K ﹤0.01% 3409
2024
Q3 		– Sell
-2,241
Closed -$44K – 2754
2024
Q2 		$44K Buy
+2,241
New +$39.6K ﹤0.01% 1848

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial's IMA Position: Q1 2026 in Review

HRT Financial opened a new position in ImageneBio Inc (IMA) in Q1 2026: 13,909 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #3409 among its holdings. This is a return to the name: HRT Financial previously reported a position in IMA as recently as Q2 2024.

HRT Financial first reported a position in IMA in Q2 2024 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • HRT Financial held 13,909 shares of ImageneBio Inc worth $69K as of Q1 2026.
  • ImageneBio Inc was a new HRT Financial position in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3409 holding.
  • HRT Financial first reported a position in ImageneBio Inc in Q2 2024 and has held it in 2 quarters since.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.